Amphastar Pharmaceuticals
AMPH
#3960
Rank
HK$19.11 B
Marketcap
HK$390.45
Share price
0.62%
Change (1 day)
8.42%
Change (1 year)

EPS for Amphastar Pharmaceuticals (AMPH)

EPS in 2023 (TTM): HK$16.45

According to Amphastar Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$16.37. In 2022 the company made an earnings per share (EPS) of HK$14.58 an increase over its 2021 EPS that were of HK$10.13.

EPS history for Amphastar Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$16.4512.86%
2022HK$14.5843.85%
2021HK$10.133521.88%
2020HK$0.28-96.55%
2019HK$8.11-900%
2018-HK$1.01-238.6%
2017HK$0.73-60.92%
2016HK$1.87-500%
2015-HK$0.47-75.74%
2014-HK$1.93-116.68%
2013HK$11.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$0.86-105.24%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$7.33-55.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$308.37-1,983.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$107.12-754.40%๐Ÿ‡บ๐Ÿ‡ธ USA